Silo Pharma, Inc. (SILO): 6 insider purchases in the last two years (4 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 16, 2025 | Weisblum Eric Director, Officer | 5,000 | $0.41 | $2.1K | routine |
| Nov 21, 2025 | Weisblum Eric Director, Officer | 2,000 | $0.37 | $740 | opportunistic |
| Nov 20, 2025 | Weisblum Eric Director, Officer | 12,000 | $0.40 | $4.8K | opportunistic |
| May 28, 2025 | Weisblum Eric Director, Officer | 10,000 | $0.43 | $4.3K | opportunistic |
| Dec 16, 2024 | Weisblum Eric Director, Officer | 2,500 | $0.84 | $2.1K | routine |
| Nov 22, 2024 | Weisblum Eric Director, Officer | 5,000 | $0.93 | $4.6K | opportunistic |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.